Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

Stopped slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.

Conditions

• Hypercholesterolemia
• Atherosclerosis

Interventions

• DRUG: Ezetimibe
• DRUG: Placebo

Sponsor

Organon and Co

Collaborators

• [object Object]